切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 631 -637. doi: 10.3877/cma.j.issn.2095-3224.2021.06.010

论著

肿瘤间质成熟度与结直肠癌预后关系的Meta分析
杨伟1, 陈洁静1, 吴巍1, 刘茂安1, 戴勇1, 倪庆1,()   
  1. 1. 225100 扬州大学附属医院普外科
  • 收稿日期:2021-03-26 出版日期:2021-12-25
  • 通信作者: 倪庆

The relationship between tumor stromal maturity and prognosis of colorectal cancer: a Meta analysis

Wei Yang1, Jiejing Chen1, Wei Wu1, Maoan Liu1, Yong Dai1, Qing Ni1,()   

  1. 1. Department of General Surgery, the Affiliated Hospital of Yangzhou University, Yangzhou 225100, China
  • Received:2021-03-26 Published:2021-12-25
  • Corresponding author: Qing Ni
引用本文:

杨伟, 陈洁静, 吴巍, 刘茂安, 戴勇, 倪庆. 肿瘤间质成熟度与结直肠癌预后关系的Meta分析[J]. 中华结直肠疾病电子杂志, 2021, 10(06): 631-637.

Wei Yang, Jiejing Chen, Wei Wu, Maoan Liu, Yong Dai, Qing Ni. The relationship between tumor stromal maturity and prognosis of colorectal cancer: a Meta analysis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(06): 631-637.

目的

探讨肿瘤间质成熟度与结直肠癌预后的关系。

方法

检索万方、中国知网、Cochrane Library、PubMed、SpringerLink、EBSCO、MEDLINE等数据库,以“肿瘤间质成熟度”“促纤维间质反应”“促纤维反应”“间质反应”“间质反应程度“间质分级”“间质密度”“结直肠癌”“预后”“tumor stroma maturity”“desmoplastic stroma reaction”“desmoplastic reaction”“stroma reaction”“degree of stroma reaction”“stroma classification”“stroma density”“colorectal cancer”“colon cancer”“rectal cancer”“prognosis”为检索词检索从建库至2021年1月所有研究肿瘤间质成熟度与结直肠癌预后关系的文献,提取相关临床资料和数据,根据纳入和排除标准,并根据NOS量表评估文献质量,最后采用RevMan5.4及R语言“metafor”包进行Meta分析。

结果

最终纳入15篇文献共19个队列9 849例结直肠癌患者的资料,其中成熟型4 339例(对照组),中间型3 048例(中间型组),不成熟型2 456例(不成熟型组),Meta分析结果显示:不成熟型组患者无复发生存率(HR=2.66,95%CI:2.30~3.08;P<0.00001)、无病生存率(HR=3.68,95%CI:2.33~5.81;P<0.00001)和总生存率(HR=1.70,95%CI:1.53~1.87;P<0.00001)均明显低于成熟型组(对照组);中间型组患者无复发生存率(HR=1.36,95%CI:1.17~1.59;P<0.0001)和无病生存率(HR=1.85,95%CI:1.53~2.24;P<0.0001)亦明显低于成熟型组(对照组)。

结论

肿瘤间质成熟度与结直肠癌预后密切相关。

Objective

To investigate the relationship between tumor stromal maturity and prognosis of colorectal cancer.

Methods

The literatures researching the relationship between tumor stromal maturity and prognosis of colorectal cancer were searched in the Wangfang, CNKI, CochraneLibrary, PubMed, SpringerLink, EBSCO, MEDLINE and other databases from database construction to January 2021, "tumor stroma maturity" "desmoplastic stroma reaction" "desmoplastic reaction" "stroma reaction" "degree of stroma reaction" "stroma classification" "stroma density" "colorectal cancer" "colon cancer" "rectal cancer" "prognosis" were selected as keywords, relevant clinical data were extracted according to the inclusion and exclusion criteria, and the quality of literatures were evaluated according to NOS form, the Meta-analysis was performed by RevMan5.4 and "metafor" R package.

Results

A total of 15 articles including 9 849 colorectal cancer patients in 19 cohorts were analysed in this Meta-analysis. These cohorts were composed by 4 339 patients with mature stroma (control group), 3 048 patients with intermediate stroma (intermediate group) and 2 456 patients with immature troma (immature group). The Meta-analysis results showed that there was significant difference between the immature group and control group in recurrence-free survival (HR=2.66, 95%CI: 2.30~3.08; P<0.00001), disease-free survival (HR=3.68, 95%CI: 2.33~5.81, P<0.00001) and overall survival (HR=1.70, 95%CI: 1.53~1.87; P<0.00001); there was also significant difference between the intermediate group and control group in RFS (HR=1.36, 95%CI: 1.17~1.59, P<0.0001) and DFS (HR=1.85, 95%CI: 1.53~2.24, P<0.0001).

Conclusion

The prognosis of colorectal cancer was closely related to the tumor stromal maturity.

图1 文献检索流程图
表1 纳入研究的基本特征及NOS量表评分(
xˉ
±s,例)
研究 时间 国家 研究类型 样本量 性别(男/女)

年龄

(岁)

分期 肿瘤部位(结肠/直肠) 分化程度(高/中/低) DR(不成熟/中间型/成熟) 随访时间(月) 结局 NOS评分
Ueno5 2002 英国 队列 627 393/234 60.3±12 Ⅰ~Ⅲ NA 140/402/85 72/159/396 153(80~267) OS 6
Ueno6 2004 日本 队列 862 NA NA Ⅰ~Ⅲ 直肠 NA 125/284/453 140 OS 6
Ueno7 2014 日本 队列 412 NA 61.4±12 NA 205/190/11 153/122/137 61(11~188) OS、DFS 6
Ueno(1)8 2015 日本 队列 880 512/368 62.9±13 Ⅱ~Ⅲ 609/271 256/574/50 192/275/413 68 DFS、OS 7
Ueno(2)8 2015 日本 队列 474 268/206 66.3±13 Ⅱ~Ⅲ 382/92 201/232/41 82/170/222 68 DFS、OS 8
Ueno9 2017 日本 队列 821 484/337 66.2±12 Ⅱ~Ⅲ 510/311 401/365/55 214/282/325 59(1~86) RFS、DSS 7
Ueno(1)10 2018 日本 队列 466 264/202 59.9±13 276/190 202/231/33 169/133/164 59(45~144) RFS 7
Ueno(2)10 2018 日本 队列 432 247/185 65.1±12 251/181 181/216/35 145/140/147 58(1~87) RFS 8
Shin11 2019 韩国 队列 151 88/63 63.2±11 Ⅰ~Ⅳ 47/104 11/130/5 30/91/60 56 OS 7
Konishi12 2018 美国 队列 851 407/444 66±14 Ⅰ~Ⅲ 454/397 NA 95/256/500 58 RFS 8
Nearchou(1)13 2019 日本 队列 283 184/99 62.3±11 92/76/115 145/25/113 88/105/90 NA OS 7
Nearchou(2)13 2019 英国 队列 163 87/76 63±12 65/57/41 2/93/25 28/79/56 NA OS 8
Ueno(1)14 2019 日本 队列 679 400/279 64.0±12 458/221 276/368/35 430/180/69 91 RFS、OS 8
Ueno(2)14 2019 日本 队列 446 267/179 67.0±12 287/159 253/171/22 235/142/69 58 RFS、OS 9
Gonzalez15 2020 美国 队列 342 179/163 65.2±12.6 Ⅰ~Ⅲ 204/138 148/104/90 66/133/143 NA RFS 6
Hacking16 2020 美国 队列 234 111/118 64±13 Ⅰ~Ⅲ 105/33/42 106/68/60 28/48/152 NA DFS 6
Ao17 2020 日本 队列 363 209/154 66.6±12 203/160 121/212/30 148/106/109 61(1~136) RFS 6
Gonzalez18 2021 美国 队列 372 189/183 65.7±12.9 Ⅰ~Ⅲ 227/145 294/56/22 67/140/165 62(1~170) RFS 6
Ueno19 2021 日本 队列 991 601/390 65.5 807/184 420/526/45 59/294/638 69.7(2.1~105.6) RFS 8
图2 肿瘤间质不成熟组与成熟组患者无复发生存率比较的Meta分析结果
图3 肿瘤间质中间型组与成熟组患者无复发生存率比较的Meta分析结果
图4 肿瘤间质不成熟组与成熟组患者无病生存率比较的Meta分析结果
图5 肿瘤间质中间型组与成熟组患者无病生存率比较的Meta分析结果
图6 肿瘤间质不成熟组与成熟组患者总生存率比较的Meta分析结果
图7 肿瘤间质不成熟组与成熟组患者无复发生存率比较的Meta分析漏斗图
表2 复发生存率和总生存率的Meta回归分析
[1]
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis[J]. Nature Medicine, 2013, 19(11): 1423-1437.
[2]
Micke P, Ostman A. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy[J]. Expert Opinion on Therapeutic Targets, 2005, 9(6): 1217-1233.
[3]
Reis S, Gazinska P, Hipwell JH, et al. Automated classification of breast cancer stroma maturity from histological images[J]. Ieee Transactions on Biomedical Engineering, 2017, 64(10): 2344-2352.
[4]
Son GM, Kwon MS, Shin DH, et al. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer[J]. Medicine, 2019, 98 (18): e15164.
[5]
Ueno H, Jones A, Jass JR, et al. Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in advanced rectal cancer[J]. Histopathology, 2002, 40 (4): 327-334.
[6]
Ueno H, Jones AM, Wilkinson KH, et al. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer[J]. Gut, 2004, 53 (4): 581-586.
[7]
Ueno H, Konishi T, Ishikawa Y, et al. Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis[J]. American Journal of Surgical Pathology, 2014, 38 (10): 1380-1386.
[8]
Ueno H, Shinto E, Shimazaki H, et al. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis[J]. Annals of Surgical Oncology, 2015, 22(5): 1504-1512.
[9]
Ueno H, Kanemitsu Y, Sekine S, et al. Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer[J]. American Journal of Surgical Pathology, 2017, 41(11): 1506-1512.
[10]
Ueno H, Sekine S, Oshiro T, et al. Disentangling the prognostic heterogeneity of stage Ⅲ colorectal cancer through histologic stromal categorization[J]. Surgery, 2018, 163(4): 777-783.
[11]
Shin N, Son GM, Shin DH, et al. Cancer-associated fibroblasts and desmoplastic reactions related to cancer invasiveness in patients with colorectal cancer[J]. Annals of Coloproctology, 2019, 35(1): 36-46.
[12]
Konishi T, Shimada Y, Lee LH, et al. Poorly differentiated clusters predict colon cancer recurrence an in-depth comparative analysis of invasive-front prognostic markers[J]. American Journal of Surgical Pathology, 2018, 42(6): 705-714.
[13]
Nearchou IP, Kajiwara Y, Mochizuki S, et al. Novel internationally verified method reports desmoplastic reaction as the most significant prognostic feature for disease-specific survival in stageⅡcolorectal cancer[J]. American Journal of Surgical Pathology, 2019, 43 (9): 1239-1248.
[14]
Ueno H, Kanemitsu Y, Sekine S, et al. A multicenter study of the prognostic value of desmoplastic reaction categorization in stageⅡcolorectal cancer[J]. American Journal of Surgical Pathology, 2019, 43 (8): 1015-1022.
[15]
Gonzalez IA, Bauer PS, Liu J, et al. Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma[J]. Human Pathology, 2021, 107: 9-19.
[16]
Hacking S, Ebare K, Angert M, et al. Immature stroma and prognostic profiling in colorectal carcinoma: development and validation of novel classification systems[J]. Pathology Research and Practice, 2020, 216(7): 152970.
[17]
Ao T, Kajiwara Y, Yonemura K, et al. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions[J]. Virchows Archiv, 2020, 477(1): 47-55.
[18]
Gonzalez IA, Bauer PS, Liu J, et al. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages Ⅰ-Ⅲ colorectal cancer[J]. Histopathology, 2021, 78(2): 252-264.
[19]
Ueno H, Ishiguro M, Nakatani E, et al. Prognostic value of desmoplastic reaction characterisation in stage Ⅱ colon cancer: prospective validation in a Phase 3 study (SACURA Trial)[J]. British Journal of Cancer, 2021, 124: 1088-1097.
[20]
Beck AH, Sangoi AR, Leung S, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival[J]. Science Translational Medicine, 2011, 3 (108): 108ra113.
[21]
Kalluri R. The biology and function of fibroblasts in cancer[J]. Nature Reviews Cancer, 2016, 16 (9): 582-598.
[22]
Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer[J]. Journal of Clinical Pathology, 1989, 42 (2): 162-166.
[23]
Barsky SH, Gopalakrishna R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice[J]. Cancer Research, 1987, 47 (6): 1663-1667.
[24]
Coulson-Thomas VJ, Coulson-Thomas YM, Gesteira TF. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion[J]. Cell and Tissue Research, 2011, 346 (2): 223-236.
[25]
Herrera M, Islam ABMMK, Herrera A. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature[J]. Clinical Cancer Research, 2013, 19 (21): 5914-5926.
[26]
De Smedt L, Palmans S, Andel D, et al. Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching[J]. British Journal of Cancer, 2017, 116 (1): 58-65.
[27]
Ueno H, Shinto E, Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer[J]. British Journal of Cancer, 2014, 111 (11): 2082-2090.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[3] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[4] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[5] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[6] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[8] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[9] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[10] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[11] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[12] 陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要